Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.05
+0.54 (9.80%)
At close: Feb 18, 2026, 4:00 PM EST
6.07
+0.02 (0.33%)
After-hours: Feb 18, 2026, 4:04 PM EST
Verrica Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$17.00
Upside
+180.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $17 | Hold → Strong Buy | Upgrades | $17 | +180.99% | Dec 18, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $110 → $20 | Buy → Hold | Downgrades | $110 → $20 | +230.58% | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $150 → $100 | Strong Buy | Maintains | $150 → $100 | +1,552.89% | Oct 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $130 → $110 | Buy | Maintains | $130 → $110 | +1,718.18% | Oct 4, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades $120 | Strong Buy → Hold | Downgrades | $120 | +1,883.47% | Oct 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 2, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $140 → $130 | Buy | Maintains | $140 → $130 | +2,048.76% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Maintains $160 → $120 | Strong Buy | Maintains | $160 → $120 | +1,883.47% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +2,544.63% | May 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.